Otrivine Congestion Relief Nasal Spray

Otrivine is a leading nasal decongestant brand known for its active ingredient, Xylometazoline Hydrochloride, which works by constricting blood vessels in the nasal passages to clear congestion. The brand name is commonly used in UK and European markets (marketed as Otrivin in other regions).

Historically, the brand was a cornerstone of the Swiss pharmaceutical giant Ciba-Geigy, which later became part of Novartis. Following a series of strategic joint ventures and spin-offs, the consumer healthcare portfolio, including Otrivine, was transitioned to Haleon. Today, Otrivine is managed under Haleon's global respiratory health category. Manufacturing occurs across several specialist facility locations globally to meet regional demand, including sites in Switzerland and the UK.

Following the 2022 demerger from GSK, Haleon operates as an independent, world-leading consumer health company headquartered in the United Kingdom. It maintains absolute ownership of the Otrivine brand worldwide.